DAE HWA PHARM CO LTD

Company Type: Manufacturer

Company Introduction:

DAE HWA PHARM CO LTD is a distinguished South Korean pharmaceutical company primarily focused on the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products.

Established in 1984, DAE HWA PHARM CO LTD has evolved into a key player within the Korean pharmaceutical sector. The company is headquartered in Seoul, South Korea.

Its core business activities include the production of various medications, encompassing specialized oncology drugs, general prescription drugs, over-the-counter pharmaceuticals, and health functional foods. DAE HWA PHARM CO LTD operates its own comprehensive manufacturing facilities and maintains a robust research and development center.

The company is committed to innovation and technological advancement in drug development, evidenced by its strong R&D capabilities that lead to novel drug formulations and therapeutic solutions. They oversee the entire production process, ensuring stringent quality control from initial development through to the final manufactured product.

DAE HWA PHARM CO LTD Products:

* **Cephalosporin Injectables:** Omicef, Cefathal, Ceftezole, Cefpirom

* **General Injectables:** Pantozol, Dexibuprofen, Ketorolac, Loxonin

* **Oral Medications:** Olmesartan, Rosuvastatin, Atorvastatin, Amlodipine

* **Contrast Media:** Optiray

* **Others:** Medical devices, health supplements, etc. (Specific details require further investigation).